Insider Transactions in Q1 2025 at Praxis Precision Medicines, Inc. (PRAX)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Jan 12 2025	Alex Nemiroff General Counsel and Secretary	SELL Payment of exercise price or tax liability	Direct	579 -2.7%	$36,477 $63.15 P/Share
Jan 12 2025	Timothy Edwin Kelly Chief Financial Officer	SELL Payment of exercise price or tax liability	Direct	676 -2.74%	$42,588 $63.15 P/Share
Jan 12 2025	Lauren Mastrocola Principal Accounting Officer	SELL Payment of exercise price or tax liability	Direct	390 -3.59%	$24,570 $63.15 P/Share
Jan 10 2025	Alex Nemiroff General Counsel and Secretary	BUY Grant, award, or other acquisition	Direct	11,250 +34.39%	-
Jan 10 2025	Timothy Edwin Kelly Chief Financial Officer	BUY Grant, award, or other acquisition	Direct	12,500 +33.6%	-
Jan 10 2025	Marcio Souza Chief Executive Officer	BUY Grant, award, or other acquisition	Direct	37,500 +41.0%	-
Jan 10 2025	Lauren Mastrocola Principal Accounting Officer	BUY Grant, award, or other acquisition	Direct	5,000 +31.5%	-
Jan 07 2025	Timothy Edwin Kelly Chief Financial Officer	SELL Payment of exercise price or tax liability	Direct	139 -1.13%	$10,703 $77.52 P/Share
Jan 07 2025	Alex Nemiroff General Counsel and Secretary	SELL Payment of exercise price or tax liability	Direct	89 -0.86%	$6,853 $77.52 P/Share
Jan 07 2025	Lauren Mastrocola Principal Accounting Officer	SELL Payment of exercise price or tax liability	Direct	35 -0.59%	$2,695 $77.52 P/Share
Jan 07 2025	Marcio Souza Chief Executive Officer	SELL Payment of exercise price or tax liability	Direct	434 -2.57%	$33,418 $77.52 P/Share

Receive a notification when an Institution or Guru buys or sells PRAX shares.

Notify only if

Value

Get notified when an Praxis Precision Medicines, Inc. insider buys or sells PRAX shares.

Notify only if

Operation

Value

Type

Receive news related to Praxis Precision Medicines, Inc.